Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
暂无分享,去创建一个
Richard K Valicenti | Jeff M Michalski | Mack Roach | James A Purdy | A. Markoe | H. Sandler | J. Purdy | R. Valicenti | J. Michalski | C. Perez | J. Cox | M. Roach | M. Parliament | K. Winter | J. Ryu | James D Cox | Carlos A Perez | Howard M Sandler | K Winter | Janice K Ryu | Matthew B Parliament | Arnold M Markoe | J. Cox
[1] T E Schultheiss,et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.
[2] A. Markoe,et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). , 2002, International journal of radiation oncology, biology, physics.
[3] D. Cox. Regression Models and Life-Tables , 1972 .
[4] P. Rubin,et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.
[5] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[6] Patrick A Kupelian,et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[7] Warren D. D'Souza,et al. Is the α/β ratio for prostate cancer low? , 2001 .
[8] B Pickett,et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. , 1994, International journal of radiation oncology, biology, physics.
[9] P. Rubin,et al. Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06. , 1986, International journal of radiation oncology, biology, physics.
[10] A Pollack,et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. , 2000, International journal of radiation oncology, biology, physics.
[11] J. Fowler,et al. A simple analytic derivation suggests that prostate cancer α/β ratio is low , 2001 .
[12] W. Sause,et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06. , 1987, International journal of radiation oncology, biology, physics.
[13] D J Brenner,et al. Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.
[14] Duchesne Gm,et al. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .
[15] M. Zelefsky,et al. Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma , 1999, Cancer.
[16] A. Markoe,et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.
[17] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[18] Douglas L. Jones. ICRU Report 50—Prescribing, Recording and Reporting Photon Beam Therapy , 1994 .
[19] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .